dacarbazine
Showing 26 - 50 of 113
Lymphoma Trial in Southampton (bleomycin sulfate, filgrastim, pegfilgrastim)
Active, not recruiting
- Lymphoma
- bleomycin sulfate
- +10 more
-
Southampton, England, United KingdomSouthampton General Hospital
Apr 27, 2021
Advanced Hodgkin Lymphoma Trial in Worldwide (Brentuximab Vedotin, Adriamycin, Vinblastine)
Active, not recruiting
- Advanced Hodgkin Lymphoma
- Brentuximab Vedotin
- +6 more
-
Antwerp, Belgium
- +18 more
May 4, 2022
Hodgkin Lymphoma Trial in Boston (Brentuximab Vedotin, Adriamycin, Dacarbazine)
Completed
- Hodgkin Lymphoma
- Brentuximab Vedotin
- +2 more
-
Boston, Massachusetts
- +1 more
Aug 10, 2020
Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma, Ann Arbor Stage I Nodular
Recruiting
- Ann Arbor Stage I Hodgkin Lymphoma
- +13 more
- Bleomycin
- +6 more
-
Birmingham, Alabama
- +16 more
Nov 23, 2021
Hodgkin Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin, vinblastine)
Active, not recruiting
- Hodgkin Lymphoma
- brentuximab vedotin
- +5 more
-
Fountain Valley, California
- +75 more
Dec 2, 2022
Recurrent Uveal Melanoma, Stage III Uveal Melanoma AJCC v7, Stage IIIA Uveal Melanoma AJCC v7 Trial in Canada, United States
Active, not recruiting
- Recurrent Uveal Melanoma
- +5 more
- Cabozantinib S-malate
- +3 more
-
Birmingham, Alabama
- +227 more
Mar 25, 2022
Metastatic Uveal Melanoma Trial in Wirral (Dacarbazine, Sunitinib)
Completed
- Metastatic Uveal Melanoma
- Dacarbazine
- Sunitinib
-
Wirral, United KingdomClatterbridge Centre for Oncology NHS Foundation Trust
Oct 27, 2019
High-Risk Neuroblastoma Trial in Worldwide (Vincristine, Carboplatin, Etoposide)
Recruiting
- High-Risk Neuroblastoma
- Vincristine
- +13 more
-
Villejuif, Val De Marne, France
- +15 more
Sep 17, 2021
Uveal Melanoma Trial in Worldwide (IMCgp100, Dacarbazine, Ipilimumab)
Active, not recruiting
- Uveal Melanoma
- IMCgp100
- +3 more
-
Los Angeles, California
- +55 more
Mar 10, 2022
Classical Hodgkin Lymphoma, Hodgkin Lymphoma (Category), Hodgkin Disease Trial in Riyadh (Adriamycin, Cyclophosphamide,
Unknown status
- Classical Hodgkin Lymphoma
- +3 more
- Adriamycin
- +5 more
-
Riyadh, Saudi ArabiaKing Abdulaziz Medical City, Ministry of National Guard
Nov 14, 2019
Hodgkin Lymphoma Trial in Italy (Doxorubicin, Bleomycin, Vinblastine)
Active, not recruiting
- Hodgkin Lymphoma
- Doxorubicin
- +3 more
-
Alessandria, Italy
- +45 more
Dec 22, 2022
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin
Unknown status
- Adult Lymphocyte Depletion Hodgkin Lymphoma
- +6 more
- brentuximab vedotin
- +11 more
-
Stanford, California
- +6 more
Feb 14, 2020
Hodgkin Disease Trial in Worldwide (Nivolumab, Doxorubicin, Vinblastine)
Active, not recruiting
- Hodgkin Disease
- Nivolumab
- +3 more
-
Los Angeles, California
- +37 more
Oct 25, 2021
Classic Hodgkin Lymphoma, Lugano Classification Stage III Hodgkin Lymphoma AJCC v8, Lugano Classification Stage IV Hodgkin
Metastatic or Unresectable Cutaneous Melanoma Trial in Worldwide (MEK162, Dacarbazine)
Completed
- Metastatic or Unresectable Cutaneous Melanoma
- MEK162
- Dacarbazine
-
Fayetteville, Arkansas
- +228 more
Mar 18, 2021
Lymphoma Trial in Worldwide (bleomycin sulfate, filgrastim, pegfilgrastim)
Completed
- Lymphoma
- bleomycin sulfate
- +12 more
-
Garran, Australian Capital Territory, Australia
- +139 more
Dec 19, 2022
Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma, Ann Arbor Stage III
Recruiting
- Ann Arbor Stage III Hodgkin Lymphoma
- +13 more
- Brentuximab Vedotin
- +9 more
-
Birmingham, Alabama
- +731 more
Aug 24, 2022
Metastatic Melanoma Trial in Lebanon (vinblastine, Cyclophosphamide, dacarbazine)
Terminated
- Metastatic Melanoma
- vinblastine
- +2 more
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Dec 26, 2018